MedPath

HSA Approvals

Singapore Health Sciences Authority approved drug registrations and therapeutic product information

Health Sciences Authority
Singapore
5,858 Approvals
Showing 601 to 620 of 5,858 approvalsPage 31 of 293

MUREST-DR 360 DELAYED-RELEASE TABLETS 360MG

Approval Number: SIN16637P
Approval: Nov 9, 2022

MUREST-DR 180 DELAYED-RELEASE TABLETS 180MG

Approval Number: SIN16638P
Approval: Nov 9, 2022

ASADIN INJECTION 1MG/ML

Approval Number: SIN16634P
Approval: Nov 2, 2022

DUTABIT PLUS 0.5/0.4 CAPSULES 0.5MG/0.4MG

Approval Number: SIN16633P
Approval: Nov 1, 2022

HCQS HYDROXYCHLOROQUINE TABLET BP 200 mg

Approval Number: SIN16632P
Approval: Oct 28, 2022

ROVEXINE-50 TABLETS 50MCG

Approval Number: SIN16628P
Approval: Oct 10, 2022

ROVEXINE-100 TABLETS 100MCG

Approval Number: SIN16626P
Approval: Oct 10, 2022

ROVEXINE-25 TABLETS 25MCG

Approval Number: SIN16629P
Approval: Oct 10, 2022

ROVEXINE-75 TABLETS 75MCG

Approval Number: SIN16627P
Approval: Oct 10, 2022

ROSUDEX FILM-COATED TABLET 20MG

Approval Number: SIN16624P
Approval: Oct 6, 2022

ROSUDEX FILM-COATED TABLET 10MG

Approval Number: SIN16625P
Approval: Oct 6, 2022

ANASOMA 1 FILM-COATED TABLETS 1MG

Approval Number: SIN16621P
Approval: Oct 5, 2022

BEATECAVIR FILM COATED TABLET 1MG

Approval Number: SIN16619P
Approval: Oct 5, 2022

BEATECAVIR FILM COATED TABLET 0.5MG

Approval Number: SIN16620P
Approval: Oct 5, 2022

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.